Rezolute, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
Notes Tables
Notes Details

RELATED PARTY TRANSACTIONS (Details)

v3.21.1

RELATED PARTY TRANSACTIONS (Details) - USD ($) $ / shares in Units, $ in Thousands					1 Months Ended	3 Months Ended		6 Months Ended		9 Months Ended
	Dec. 31, 2020	Oct. 09, 2020	Sep. 15, 2020	Jul. 23, 2019	Jul. 23, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Mar. 31, 2021	Mar. 31, 2020
Related Party Transaction [Line Items]
Number of shares issued		2,500,000
Price per share										$ 14.50
Fair Value Adjustment of Warrants										$ 8	$ 76
Related Party Transaction, Employee Services						$ 0	$ 0	$ 0	$ 0
Master Services Agreement ("MSA")
Related Party Transaction [Line Items]
Fair Value Adjustment of Warrants									$ 100
Related Party Licensing Agreement
Related Party Transaction [Line Items]
Pharmaceutical License Agreement, Term			20 years
Pharmaceutical License Agreement, Milestone Payment			$ 500
Pharmaceutical License Agreement, Transfer Price			70.00%
Milestone payments earned			$ 0
Investor [Member]
Related Party Transaction [Line Items]
Number of shares issued	189,000			1,400,000	1,400,000
Price per share				$ 14.50	$ 14.50					$ 16.50
Gross proceeds from issuance				$ 20,000
Investor [Member] \| Master Services Agreement ("MSA")
Related Party Transaction [Line Items]
General and administrative expenses										$ 100
Handok [Member]
Related Party Transaction [Line Items]
Ownership interest by related party										24.00%
Genexine [Member]
Related Party Transaction [Line Items]
Ownership interest by related party										22.00%

- Definition

The amount of milestone payments to be incurred for the approval of license.

+ References

No definition available.

+ Details

Name:	rzlt_PharmaceuticalLicenseAgreementMilestonePayment
Namespace Prefix:	rzlt_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of milestone payments earned by the entity.

+ References

No definition available.

+ Details

Name:	rzlt_PharmaceuticalLicenseAgreementMilestonePaymentEarned
Namespace Prefix:	rzlt_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Term of pharmaceutical license agreement in years.

+ References

No definition available.

+ Details

Name:	rzlt_PharmaceuticalLicenseAgreementTerm
Namespace Prefix:	rzlt_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The percentage of transfer price on sale of products.

+ References

No definition available.

+ Details

Name:	rzlt_PharmaceuticalLicenseAgreementTransferPrice
Namespace Prefix:	rzlt_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The related party interest in net assets of the entity, expressed as a percentage.

+ References

No definition available.

+ Details

Name:	rzlt_RelatedPartnershipOwnershipInterest
Namespace Prefix:	rzlt_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Represents the amount of expense related to employee services.

+ References

No definition available.

+ Details

Name:	rzlt_RelatedPartyTransactionEmployeeServices
Namespace Prefix:	rzlt_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of expense (income) related to adjustment to fair value of warrant liability.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section 25
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875

+ Details

Name:	us-gaap_FairValueAdjustmentOfWarrants
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.

+ References

No definition available.

+ Details

Name:	us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=rzlt_MasterServicesAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=rzlt_RelatedPartyLicensingAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rzlt_HandokMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rzlt_GenexineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: